Age-dependent regulation of renal vasopressin V1A and V 2 receptors in rats with genetic hypertension: Implications for the treatment of hypertension

Journal of the American Society of Hypertension

Volumn 7, Issue 1, 2013, Pages 3-13

  Burrell, Louise M ^a   Risvanis, John ^a   Dean, Rachael G ^a   Patel, Sheila K ^a   Velkoska, Elena ^a   Johnston, Colin I ^b  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

Author keywords

Arginine vasopressin; hypertension; kidney; prehypertension; SHR; vasopressin receptor antagonists

Indexed keywords

ARGIPRESSIN; RENIN; VASOPRESSIN RECEPTOR ANTAGONIST; VASOPRESSIN V1A RECEPTOR; VASOPRESSIN V2 RECEPTOR;

ADRENAL MEDULLA; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; FLUID INTAKE; GENE EXPRESSION; HEREDITARY HYPERTENSION; MALE; NONHUMAN; PLASMA RENIN ACTIVITY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; RAT; REGULATORY MECHANISM; SPONTANEOUSLY HYPERTENSIVE RAT; SYSTOLIC BLOOD PRESSURE; URINE VOLUME;

AGE FACTORS; ANIMALS; ANTIHYPERTENSIVE AGENTS; ARGININE VASOPRESSIN; DISEASE MODELS, ANIMAL; DRINKING; HYPERTENSION, RENAL; IODINE RADIOISOTOPES; KIDNEY MEDULLA; MALE; PREHYPERTENSION; RADIOLIGAND ASSAY; RATS; RATS, INBRED SHR; RATS, SPRAGUE-DAWLEY; RECEPTORS, VASOPRESSIN; RENIN; RNA, MESSENGER; SPECIES SPECIFICITY; URINE;

EID: 84872302176     PISSN: 19331711     EISSN: 18787436     Source Type: Journal    
DOI: 10.1016/j.jash.2012.11.004     Document Type: Article

References (68)

1. C.I. Johnston Vasopressin in circulatory control and hypertension J Hypertens 3 1985 557 569
2. K.H. Berecek, and B.H. Swords Central role for vasopressin in cardiovascular regulation and the pathogenesis of hypertension Hypertension 16 1990 213 224
3. D. Bolignano, and C. Zoccali Vasopressin beyond water: implications for renal diseases Curr Opin Nephrol Hypertens 19 2010 499 504
4. F.C. Luft Vasopressin, urine concentration, and hypertension: a new perspective on an old story Clin J Am Soc Nephrol 2 2007 196 197
5. L.M. Burrell, P.A. Phillips, J.M. Stephenson, J. Risvanis, K.A. Rolls, and C.I. Johnston Blood pressure-lowering effect of an orally active vasopressin V1 receptor antagonist in mineralocorticoid hypertension in the rat Hypertension 23 1994 737 743
6. U. Ganten, W. Rascher, R.E. Lang, R. Dietz, R. Rettig, and T. Unger Development of a new strain of spontaneously hypertensive rats homozygous for hypothalamic diabetes insipidus Hypertension 5 1983 I119 I128
7. J.S. Simon, M.J. Brody, and B.G. Kasson Characterization of a vasopressin-like peptide in rat and bovine blood vessels Am J Physiol 262 1992 H799 H805
8. L.M. Burrell, P.A. Phillips, J. Risvanis, K.L. Aldred, A.M. Hutchins, and C.I. Johnston Attenuation of genetic hypertension after short-term vasopressin V1A receptor antagonism Hypertension 26 1995 828 834
9. M. Naitoh, L.M. Burrell, J. Risvanis, K.L. Aldred, M.D. Rockell, and C.I. Johnston Modulation of genetic hypertension by short-term AVP V1A or V2 receptor antagonism in young SHR Am J Physiol 272 1997 F229 F234
10. A.W. Cowley Jr., E. Szczepanska-Sadowska, K. Stepniakowski, and D. Mattson Chronic intravenous administration of V1 arginine vasopressin agonist results in sustained hypertension Am J Physiol 267 1994 H751 H756
11. E. Szczepanska-Sadowska, K. Stepniakowski, M.M. Skelton, and A.W. Cowley Jr. Prolonged stimulation of intrarenal V1 vasopressin receptors results in sustained hypertension Am J Physiol 267 1994 R1217 R1225
12. T. Aoyagi, T.A. Koshimizu, and A. Tanoue Vasopressin regulation of blood pressure and volume: findings from V1a receptor-deficient mice Kidney Int 76 2009 1035 1039
13. R. Oikawa, C. Hosoda, Y. Nasa, T. Daicho, A. Tanoue, and G. Tsujimoto Decreased susceptibility to salt-induced hypertension in subtotally nephrectomized mice lacking the vasopressin V1a receptor Cardiovasc Res 87 2010 187 194
14. A.W. Cowley Jr., M.M. Skelton, and T.M. Kurth Effects of long-term vasopressin receptor stimulation on medullary blood flow and arterial pressure Am J Physiol 275 1998 R1420 R1424
15. M. Naitoh, H. Suzuki, M. Murakami, A. Matsumoto, A. Ichihara, and H. Nakamoto Arginine vasopressin produces renal vasodilation via V2 receptors in conscious dogs Am J Physiol 265 1993 R934 R942
16. F. Park, D.L. Mattson, M.M. Skelton, and A.W. Cowley Jr. Localization of the vasopressin V1a and V2 receptors within the renal cortical and medullary circulation Am J Physiol 273 1997 R243 R251
17. B.O. Vagnes, F.H. Hansen, R.E. Christiansen, C. Gjerstad, and B.M. Iversen Age-dependent regulation of vasopressin V1a receptors in preglomerular vessels from the spontaneously hypertensive rat Am J Physiol Renal Physiol 286 2004 F997 1003
18. O. Vagnes, J.J. Feng, B.M. Iversen, and W.J. Arendshorst Upregulation of V(1) receptors in renal resistance vessels of rats developing genetic hypertension Am J Physiol Renal Physiol 278 2000 F940 F948
19. O.B. Vagnes, F.H. Hansen, J.J. Feng, B.M. Iversen, and W.J. Arendshorst Enhanced Ca2+ response to AVP in preglomerular vessels from rats with genetic hypertension during different hydration states Am J Physiol Renal Physiol 288 2005 F1249 F1256
20. P.A. Phillips, J.M. Abrahams, J.M. Kelly, V. Mooser, D. Trinder, and C.I. Johnston Localization of vasopressin binding sites in rat tissues using specific V1 and V2 selective ligands Endocrinology 126 1990 1478 1484
21. C. Serradeil-Le Gal, D. Raufaste, E. Marty, C. Garcia, J.P. Maffrand, and G. Le Fur Autoradiographic localization of vasopressin V1a receptors in the rat kidney using [3H]-SR 49059 Kidney Int 50 1996 499 505
22. M.P. Arpin-Bott, E. Waltisperger, M.J. Freund-Mercier, and M.E. Stoeckel Historadioautographic localization, pharmacology and ontogeny of V(1a) vasopressin binding sites in the rat kidney Nephron 83 1999 74 84
23. M. Carmosino, H.L. Brooks, Q. Cai, L.S. Davis, S. Opalenik, and C. Hao Axial heterogeneity of vasopressin-receptor subtypes along the human and mouse collecting duct Am J Physiol Renal Physiol 292 2007 F351 F360
24. M. Hosoya, T. Ogura, H. Watanabe, Z. Ota, and Z. Kageyama Autoradiographic localization and age-related changes in vasopressin receptors in spontaneously hypertensive rats Nephron 72 1996 281 287
25. A. Tahara, J. Tsukada, Y. Tomura, K. Wada, T. Kusayama, and N. Ishii Alterations of renal vasopressin V1A and V2 receptors in spontaneously hypertensive rats Pharmacology 67 2003 106 112
26. D. Trinder, J.M. Stephenson, X. Gao, P.A. Phillips, J. Risvanis, and C.I. Johnston [3H]desGly-NH2(9)-d(CH2)5[D-Ileu2, Ileu4]AVP: an AVP V2 receptor antagonist radioligand Peptides 12 1991 1195 1200
27. J. Risvanis, M. Naitoh, C.I. Johnston, and L.M. Burrell In vivo and in vitro characterisation of a nonpeptide vasopressin V(1A) and V(2) receptor antagonist (YM087) in the rat Eur J Pharmacol 381 1999 23 30
28. S.B. Harrap Genetic analysis of blood pressure and sodium balance in spontaneously hypertensive rats Hypertension 8 1986 572 582
29. T.W. Kurtz, and R.C. Morris Jr. Biological variability in Wistar-Kyoto rats. Implications for research with the spontaneously hypertensive rat Hypertension 10 1987 127 131
30. P.T. Pullan, C.I. Johnston, W.P. Anderson, and P.I. Korner The role of vasopressin in blood pressure control and in experimental hypertension Clin Sci Mol Med Suppl 4 1978 251s 254s
31. C.I. Johnston, F. Mendelsohn, and D. Casley Evaluation of renin and angiotensin assays and their clinical application Med J Aust 1 1971 126 128
32. J.J. Feng, and W.J. Arendshorst Enhanced renal vasoconstriction induced by vasopressin in SHR is mediated by V1 receptors Am J Physiol 271 1996 F304 F313
33. X.P. Yang, R.M. Touyz, P.V. Nguyen, L.Y. Deng, J.S. Li, and E.L. Schiffrin Endothelin-1 and vasopressin signalling in blood vessels of young SHR in comparison to adult SHR Hypertens Res 19 1996 121 132
34. R. Lariviere, J. Baribeau, J. St-Louis, and E.L. Schiffrin Vasopressin receptors and inositol trisphosphate production in blood vessels of spontaneously hypertensive rats Can J Physiol Pharmacol 67 1989 232 239
35. J.J. Liu, P.A. Phillips, L.M. Burrell, B.B. Buxton, and C.I. Johnston Human internal mammary artery responses to non-peptide vasopressin antagonists Clin Exp Pharmacol Physiol 21 1994 121 124
36. J.J. Liu, J.R. Chen, B.B. Buxton, C.I. Johnston, and L.M. Burrell Potent inhibitory effect of SR 49059, an orally active non-peptide vasopressin VIa receptor antagonist, on human arterial coronary bypass graft Clin Sci (Lond) 89 1995 481 485
37. W. Kriz Structural organization of renal medullary circulation Nephron 31 1982 290 295
38. A.W. Cowley Jr. Control of the renal medullary circulation by vasopressin V1 and V2 receptors in the rat Exp Physiol 85 Spec No 2000 223S 231S
39. W. Kriz, and H. Dieterich The supplying and draining vessels of the renal medulla in mammals Karger Proceedings 4th International Congress Nephrology 1969 Karger Stockholm: Basel/Munich/New York 138 144
40. L. Bankir Vasopressin and the urinary concentrating mechanism S. Jard, R. Jamieson, Vasopressin 1990 John Libbey Eurotext Montpellier, France 437 447
41. N.L. Ostrowski, W.S. Young 3rd, M.A. Knepper, and S.J. Lolait Expression of vasopressin V1a and V2 receptor messenger ribonucleic acid in the liver and kidney of embryonic, developing, and adult rats Endocrinology 133 1993 1849 1859
42. R.D. Bunag, I.H. Page, and J.W. McCubbin Inhibition of renin release by vasopressin and angiotensin Cardiovasc Res 1 1967 67 73
43. A.J. Vander Inhibition of renin release in the dog by vasopressin and vasotocin Circ Res 23 1968 605 609
44. I.A. Reid, J. Schwartz, L. Ben, J. Maselli, and L.C. Keil Interactions between vasopressin and the renin-angiotensin system Progr Brain Res 60 1983 475 491
45. I. Os, S.E. Kjeldsen, J. Skjoto, A. Westheim, K. Lande, and I. Aakesson Increased plasma vasopressin in low renin essential hypertension Hypertension 8 1986 506 513
46. D. Mouw, J.P. Bonjour, R.L. Malvin, and A. Vander Central action of angiotensin in stimulating ADH release Am J Physiol 220 1971 239 242
47. P.L. Padfield, and J.J. Morton Effects of angiotensin II on arginine-vasopressin in physiological and pathological situations in man J Endocrinol 74 1977 251 259
48. L.M. Burrell, J. Risvanis, P.A. Phillips, M. Naitoh, and C.I. Johnston Chronic vasopressin antagonism in two-kidney, one-clip renovascular hypertension Clin Exp Hypertens 19 1997 981 991
49. T.B. Fraser, S.W. Turner, C. Wen, M. Li, L.M. Burrell, and J.A. Whitworth Vasopressin V1a receptor antagonism does not reverse adrenocorticotrophin- induced hypertension in the rat Clin Exp Pharmacol Physiol 27 2000 866 870
50. C. Loichot, C. Cazaubon, M. Grima, W. De Jong, D. Nisato, and J.L. Imbs Vasopressin does not effect hypertension caused by long-term nitric oxide inhibition Hypertension 35 2000 602 608
51. D.B. Sampey, L.M. Burrell, and R.E. Widdop Vasopressin V2 receptor enhances gain of baroreflex in conscious spontaneously hypertensive rats Am J Physiol 276 1999 R872 R879
52. T. Unger, P. Rohmeiss, G. Demmert, D. Ganten, R.E. Lang, and F.C. Luft Differential modulation of the baroreceptor reflex by brain and plasma vasopressin Hypertension 8 1986 II157 II162
53. R. Veelken, L. Danckwart, P. Rohmeiss, and T. Unger Effects of intravenous AVP on cardiac output, mesenteric hemodynamics, and splanchnic nerve activity Am J Physiol 257 1989 H658 H664
54. S.B. Harrap, W.M. Van der Merwe, S.A. Griffin, F. Macpherson, and A.F. Lever Brief angiotensin converting enzyme inhibitor treatment in young spontaneously hypertensive rats reduces blood pressure long-term Hypertension 16 1990 603 614
55. R. McCarty, and J.H. Lee Preweanling administration of terazosin decreases blood pressure of hypertensive rats in adulthood Hypertension 27 1996 1115 1120
56. M. Buemi, L. Nostro, G. Di Pasquale, E. Cavallaro, A. Sturiale, and F. Floccari Aquaporin-2 water channels in spontaneously hypertensive rats Am J Hypertens 17 2004 1170 1178
57. X. Zhang, H.W. Hense, G.A. Riegger, and H. Schunkert Association of arginine vasopressin and arterial blood pressure in a population-based sample J Hypertens 17 1999 319 324
58. C.J. Thompson, S.N. Davis, P.C. Butler, J.A. Charlton, and P.H. Baylis Osmoregulation of thirst and vasopressin secretion in insulin-dependent diabetes mellitus Clin Sci (Lond) 74 1988 599 606
59. G. Bakris, M. Bursztyn, I. Gavras, M. Bresnahan, and H. Gavras Role of vasopressin in essential hypertension: racial differences J Hypertens 15 1997 545 550
60. L. Bankir, J. Perucca, and M.H. Weinberger Ethnic differences in urine concentration: possible relationship to blood pressure Clin J Am Soc Nephrol 2 2007 304 312
61. L. Bankir, D.G. Bichet, and N. Bouby Vasopressin V2 receptors, ENaC, and sodium reabsorption: a risk factor for hypertension? Am J Physiol Renal Physiol 299 2010 F917 F928
62. A.V. Chobanian, G.L. Bakris, H.R. Black, W.C. Cushman, L.A. Green, and J.L. Izzo Jr. Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure Hypertension 42 2003 1206 1252
63. C. Lenfant, A.V. Chobanian, D.W. Jones, and E.J. Roccella Seventh report of the Joint National Committee on the Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC 7): resetting the hypertension sails Hypertension 41 2003 1178 1179
64. E.D. Frohlich Epidemiological issues are not simply black and white Hypertension 58 4 2011 546 547
65. A. Selassie, C.S. Wagner, M.L. Laken, M.L. Ferguson, K.C. Ferdinand, and B.M. Egan Progression is accelerated from prehypertension to hypertension in blacks Hypertension 58 4 2011 579 587
66. S. Julius, N. Kaciroti, B.M. Egan, S. Nesbitt, and E.L. Michelson TROPHY study: outcomes based on the Seventh Report of the Joint National Committee on Hypertension definition of hypertension J Am Soc Hypertens 2 2008 39 43
67. R. Weber, A. Pechere-Bertschi, D. Hayoz, V. Gerc, R. Brouard, and J.P. Lahmy Effects of SR 49059, a new orally active and specific vasopressin V1 receptor antagonist, on vasopressin-induced vasoconstriction in humans Hypertension 30 1997 1121 1127
68. D. Hayoz, G. Bizzini, B. Noel, M. Depairon, M. Burnier, and C. Fauveau Effect of SR 49059, a V1a vasopressin receptor antagonist, in Raynaud's phenomenon Rheumatology 39 2000 1132 1138